CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | MORROW GEORGE J Director | Option exercise 10b5-1 | +300 | $53.64 | $16K | 10,686 |
| 2026-10-30 | MORROW GEORGE J Director | Sale 10b5-1 | −300 | $149.00 | $45K | 10,386 |
| 2026-10-30 | MORROW GEORGE J Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −300 | 14,700 | ||
| 2026-09-14 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −826 | $157.45 | $130K | 8,722 |
| 2026-09-14 | ABERNETHY MATT Chief Financial Officer | Sale 10b5-1 | −2,311 | $157.20 | $363K | 42,808 |
| 2026-09-11 | Delaet Ingrid Chief Regulatory Officer | Grant or award | +4,483 | 20,708 | ||
| 2026-09-11 | Delaet Ingrid Chief Regulatory Officer | Shares withheld for taxes | −2,419 | $156.22 | $378K | 18,289 |
| 2026-09-11 | Boyer David W. Chief Corp. Affairs Officer | Grant or award 10b5-1 | +3,587 | 11,484 | ||
| 2026-09-11 | Boyer David W. Chief Corp. Affairs Officer | Shares withheld for taxes 10b5-1 | −1,936 | $156.22 | $302K | 9,548 |
| 2026-09-11 | Onyia Jude Chief Scientific Officer | Grant or award | +3,587 | 24,583 | ||
| 2026-09-11 | Onyia Jude Chief Scientific Officer | Shares withheld for taxes | −1,936 | $156.22 | $302K | 22,647 |
| 2026-09-11 | Keswani Sanjay Chandru Chief Medical Officer | Grant or award | +3,914 | 5,393 | ||
| 2026-09-11 | Keswani Sanjay Chandru Chief Medical Officer | Shares withheld for taxes | −2,112 | $156.22 | $330K | 3,281 |
| 2026-09-11 | Cooke Julie Chief Human Resources Officer | Grant or award | +3,587 | 25,961 | ||
| 2026-09-11 | Cooke Julie Chief Human Resources Officer | Shares withheld for taxes | −1,936 | $156.22 | $302K | 24,025 |
| 2026-09-11 | ABERNETHY MATT Chief Financial Officer | Grant or award 10b5-1 | +5,020 | 47,828 | ||
| 2026-09-11 | ABERNETHY MATT Chief Financial Officer | Shares withheld for taxes 10b5-1 | −2,709 | $156.22 | $423K | 45,119 |
| 2026-09-11 | BENEVICH ERIC Chief Commercial Officer | Grant or award | +6,275 | 70,683 | ||
| 2026-09-11 | BENEVICH ERIC Chief Commercial Officer | Shares withheld for taxes | −3,386 | $156.22 | $529K | 67,297 |
| 2026-09-11 | Gano Kyle Chief Executive Officer | Grant or award | +6,275 | 157,266 |
Page 2 of 37 · 740 trades